The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Outlook 2024
Synopsis
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at US$ 2328 million in 2020 and is expected to reach US$ 2139.8 million by the end of 2027, growing at a CAGR of -1.6% during 2021-2027.
This report focuses on Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
5-HT3 Inhibitors
NK1 Inhibitors
Others
Segment by Application
Acute CINV
Delayed CINV
Breakthrough CINV
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.
North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market was valued at US$ 2328 million in 2020 and is expected to reach US$ 2139.8 million by the end of 2027, growing at a CAGR of -1.6% during 2021-2027.
This report focuses on Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
5-HT3 Inhibitors
NK1 Inhibitors
Others
Segment by Application
Acute CINV
Delayed CINV
Breakthrough CINV
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
Index1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Overview
1.1 Product Overview and Scope of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Type
1.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Segment by Application
1.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Acute CINV
1.3.3 Delayed CINV
1.3.4 Breakthrough CINV
1.3.5 Others
1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Estimates and Forecasts
1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2016-2027
1.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2016-2027
1.4.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region: 2016 Versus 2021 Versus 2027
2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competition by Manufacturers
2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Competitive Situation and Trends
2.5.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue
2.5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario by Region
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.3.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
3.3.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.4.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
3.4.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region
3.5.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.6.1 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
3.6.2 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country
3.7.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Analysis by Type
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2016-2021)
5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Analysis by Application
5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Heron Therapeutics
6.1.1 Heron Therapeutics Corporation Information
6.1.2 Heron Therapeutics Description and Business Overview
6.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.1.5 Heron Therapeutics Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Eisai
6.3.1 Eisai Corporation Information
6.3.2 Eisai Description and Business Overview
6.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.3.5 Eisai Recent Developments/Updates
6.4 Mundipharma
6.4.1 Mundipharma Corporation Information
6.4.2 Mundipharma Description and Business Overview
6.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.4.5 Mundipharma Recent Developments/Updates
6.5 Qilu Pharma
6.5.1 Qilu Pharma Corporation Information
6.5.2 Qilu Pharma Description and Business Overview
6.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.5.5 Qilu Pharma Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Roche
6.8.1 Roche Corporation Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Baxter
6.10.1 Baxter Corporation Information
6.10.2 Baxter Description and Business Overview
6.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.10.5 Baxter Recent Developments/Updates
6.11 GSK
6.11.1 GSK Corporation Information
6.11.2 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.11.5 GSK Recent Developments/Updates
6.12 Helsinn
6.12.1 Helsinn Corporation Information
6.12.2 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.12.5 Helsinn Recent Developments/Updates
6.13 Southwest Pharma
6.13.1 Southwest Pharma Corporation Information
6.13.2 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.13.5 Southwest Pharma Recent Developments/Updates
6.14 Haisco
6.14.1 Haisco Corporation Information
6.14.2 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.14.5 Haisco Recent Developments/Updates
6.15 Sun Pharma
6.15.1 Sun Pharma Corporation Information
6.15.2 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Description and Business Overview
6.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Portfolio
6.15.5 Sun Pharma Recent Developments/Updates
7 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Cost Analysis
7.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
7.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
8.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
9 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Dynamics
9.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
9.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Growth Drivers
9.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
9.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
10 Global Market Forecast
10.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2022-2027)
10.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application (2022-2027)
10.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Comparison by Application (2021-2027)
Table 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Covered in This Study
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) of Key Manufacturers (2016-2021)
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021) & (M Units)
Table 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 19. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 23. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021) & (M Units)
Table 27. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 31. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 35. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Type (2016-2021)
Table 39. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Type (2016-2021)
Table 42. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Type (2016-2021)
Table 43. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Application (2016-2021)
Table 44. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Application (2016-2021)
Table 47. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Application (2016-2021)
Table 48. Heron Therapeutics Corporation Information
Table 49. Heron Therapeutics Description and Business Overview
Table 50. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 52. Heron Therapeutics Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 57. Merck Recent Developments/Updates
Table 58. Eisai Corporation Information
Table 59. Eisai Description and Business Overview
Table 60. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 62. Eisai Recent Developments/Updates
Table 63. Mundipharma Corporation Information
Table 64. Mundipharma Description and Business Overview
Table 65. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 67. Mundipharma Recent Developments/Updates
Table 68. Qilu Pharma Corporation Information
Table 69. Qilu Pharma Description and Business Overview
Table 70. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 72. Qilu Pharma Recent Developments/Updates
Table 73. Teva Corporation Information
Table 74. Teva Description and Business Overview
Table 75. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 77. Teva Recent Developments/Updates
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Business Overview
Table 80. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 82. Novartis Recent Developments/Updates
Table 83. Roche Corporation Information
Table 84. Roche Description and Business Overview
Table 85. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 87. Roche Recent Developments/Updates
Table 88. Mylan Corporation Information
Table 89. Mylan Description and Business Overview
Table 90. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 92. Mylan Recent Developments/Updates
Table 93. Baxter Corporation Information
Table 94. Baxter Description and Business Overview
Table 95. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 97. Baxter Recent Developments/Updates
Table 98. GSK Corporation Information
Table 99. GSK Description and Business Overview
Table 100. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 102. GSK Recent Developments/Updates
Table 103. Helsinn Corporation Information
Table 104. Helsinn Description and Business Overview
Table 105. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 107. Helsinn Recent Developments/Updates
Table 108. Southwest Pharma Corporation Information
Table 109. Southwest Pharma Description and Business Overview
Table 110. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 112. Southwest Pharma Recent Developments/Updates
Table 113. Haisco Corporation Information
Table 114. Haisco Description and Business Overview
Table 115. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 117. Haisco Recent Developments/Updates
Table 118. Sun Pharma Corporation Information
Table 119. Sun Pharma Description and Business Overview
Table 120. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 122. Sun Pharma Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
Table 126. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers List
Table 127. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Trends
Table 128. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Growth Drivers
Table 129. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
Table 130. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
Table 131. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2022-2027) & (M Units)
Table 132. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 133. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 134. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 135. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2022-2027) & (M Units)
Table 136. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Application (2022-2027)
Table 137. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 138. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 139. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (2022-2027) & (M Units)
Table 140. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 141. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 142. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Type in 2020 & 2027
Figure 3. 5-HT3 Inhibitors Product Picture
Figure 4. NK1 Inhibitors Product Picture
Figure 5. Others Product Picture
Figure 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Application in 2020 & 2027
Figure 7. Acute CINV
Figure 8. Delayed CINV
Figure 9. Breakthrough CINV
Figure 10. Others
Figure 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size 2016-2027 (US$ Million)
Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2016-2027 (M Units)
Figure 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Manufacturers in 2020
Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players: Market Share by Revenue in 2020
Figure 18. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2021)
Figure 20. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region in 2020
Figure 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2016-2021)
Figure 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region in 2020
Figure 23. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. China Taiwan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type (2016-2021)
Figure 46. Sales Market Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application (2016-2021)
Figure 47. Sales Market Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application in 2020
Figure 48. Revenue Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application (2016-2021)
Figure 49. Revenue Share of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application in 2020
Figure 50. Manufacturing Cost Structure of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 51. Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 52. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
